These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32473614)

  • 61. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J; Luo Z; Yao T; Li W; Pu J
    J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma.
    Xiao Y; Chen B; Yang K; Wang Q; Liu P; Gu Y; Zhong Q; Liu Z; He Y; Liu Q
    Exp Cell Res; 2019 Oct; 383(2):111542. PubMed ID: 31381879
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma.
    Zhuang L; Zhang Y; Meng Z; Yang Z
    Cancer Control; 2020; 27(1):1073274820977149. PubMed ID: 33269607
    [TBL] [Abstract][Full Text] [Related]  

  • 65. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
    Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.
    Tao J; Ji J; Li X; Ding N; Wu H; Liu Y; Wang XW; Calvisi DF; Song G; Chen X
    Oncotarget; 2015 Mar; 6(9):6977-88. PubMed ID: 25762642
    [TBL] [Abstract][Full Text] [Related]  

  • 68. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.
    Kopanja D; Pandey A; Kiefer M; Wang Z; Chandan N; Carr JR; Franks R; Yu DY; Guzman G; Maker A; Raychaudhuri P
    J Hepatol; 2015 Aug; 63(2):429-36. PubMed ID: 25828473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.
    Bonnin M; Fares N; Testoni B; Estornes Y; Weber K; Vanbervliet B; Lefrançois L; Garcia A; Kfoury A; Pez F; Coste I; Saintigny P; Viari A; Lang K; Guey B; Hervieu V; Bancel B; Bartoch B; Durantel D; Renno T; Merle P; Lebecque S
    J Hepatol; 2019 Oct; 71(4):763-772. PubMed ID: 31220470
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway.
    Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS
    Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression.
    Kido T; Lau YC
    Cell Biosci; 2019; 9():22. PubMed ID: 30867900
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
    Feng T; Dzieran J; Gu X; Marhenke S; Vogel A; Machida K; Weiss TS; Ruemmele P; Kollmar O; Hoffmann P; Grässer F; Allgayer H; Fabian J; Weng HL; Teufel A; Maass T; Meyer C; Lehmann U; Zhu C; Mertens PR; Gao CF; Dooley S; Meindl-Beinker NM
    Clin Sci (Lond); 2015 Jun; 128(11):761-74. PubMed ID: 25602745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    Chandrashekar DS; Golonka RM; Yeoh BS; Gonzalez DJ; Heikenwälder M; Gerwirtz AT; Varambally S; Vijay-Kumar M
    PLoS One; 2020; 15(6):e0234726. PubMed ID: 32559205
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
    Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
    [TBL] [Abstract][Full Text] [Related]  

  • 76. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.
    Ho C; Wang C; Mattu S; Destefanis G; Ladu S; Delogu S; Armbruster J; Fan L; Lee SA; Jiang L; Dombrowski F; Evert M; Chen X; Calvisi DF
    Hepatology; 2012 Mar; 55(3):833-45. PubMed ID: 21993994
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
    Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
    Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.